Verkarre V, Bibeau F [The inherited cancers, the pathologist]. Ann Pathol. 2020;40(2):61-62. doi:10.1016/j.annpat.2020.02.016
Cohen R, Pudlarz T, Garcia-Larnicol M-L, Vernerey D, Dray X, Clavel L, Jary M, Piessen G, Zaanan A, Aparicio T, Louvet C, Tournigand C, Chibaudel B, Tougeron D, Guimbaud R, Benouna J, Adenis A, Sokol H, Borg C, Duval A, Svrcek M, André T [Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. Bull Cancer. 2020;107(4):438-446. doi:10.1016/j.bulcan.2019.11.016
Adenis A, Samalin E, Mazard T, Portales F, Mourregot A, Ychou M [Does the FLOT regimen a new standard of perioperative chemotherapy for localized gastric cancer?]. Bull Cancer. Jan 21, 2020. doi:10.1016/j.bulcan.2019.12.005
Samalin E, Adenis A TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?. Lancet Oncol.. Jul 16, 2020. doi:10.1016/S1470-2045(20)30337-5
Khashper A, Addley H, Abourokbah N, Nougaret S, Sala E, Reinhold C T2-Hypointense Adnexal Lesions: An Imaging Algorithm. Radiographics. 2020;40(4):1200. doi:10.1148/rg.2020204005
Samalin E, Fouchardière C, Boige V, Senellart H, Guimbaud R, Galais M-P, Lièvre A, Seitz J-F, Metges J-P, Bouché O, Boissière-Michot F, Lopez-Crapez E, Bibeau F, Ho-Pun-Cheung A, Ychou M, Adenis A, Di Fiore F, Mazard T Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27). Clin Colorectal Cancer. May 15, 2020. doi:10.1016/j.clcc.2020.04.008
Thierry A SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure. Clin. Sci.. 2020;134(12):1295-1300. doi:10.1042/CS20200531
Nougaret S, Monsonis B, Molinari N, Piron L, Kassam Z, Cassinotto C, Guiu B Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI. Eur Radiol. 2020-4-22. doi:10.1007/s00330-020-06757-1
Delattre J-F, Cohen R, Henriques J, Falcoz A, Emile J-F, Fratte S, Chibaudel B, Dauba J, Dupuis O, Bécouarn Y, Bibeau F, Taieb J, Louvet C, Vernerey D, André T, Svrcek M Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR). JCO. 2020-03-13. doi:10.1200/JCO.19.01960
Maciel C, Bharwani N, Kubik-Huch R, Manganaro L, Otero-Garcia M, Nougaret S, Alt C, Cunha T, Forstner R MRI of female genital tract congenital anomalies: European Society of Urogenital Radiology (ESUR) guidelines. Eur Radiol. 2020-3-27. doi:10.1007/s00330-020-06750-8
Bascoul-Mollevi C, Barbieri A, Bourgier C, Conroy T, Chauffert B, Hebbar M, Jacot W, Juzyna B, Gourgou S, Bonnetain F, Touraine C, Anota A Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results. Qual Life Res. Aug 18, 2020. doi:10.1007/s11136-020-02605-3
Selvy M, Pereira B, Kerckhove N, Gonneau C, Feydel G, Pétorin C, Vimal-Baguet A, Melnikov S, Kullab S, Hebbar M, Bouché O, Slimano F, Bourgeois V, Lebrun-Ly V, Thuillier F, Mazard T, Tavan D, Benmammar K, Monange B, Ramdani M, Péré-Vergé D, Huet-Penz F, Bedjaoui A, Genty F, Leyronnas C, Busserolles J, Trevis S, Pinon V, Pezet D, Balayssac D Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study. J Clin Med. 2020;9(8). doi:10.3390/jcm9082400
Bibeau F, Léger A, Bazille C, Selves J Les cancers colorectaux héréditaires vus par le pathologiste. Annales de Pathologie. 2020;40(2):105-113. doi:10.1016/j.annpat.2020.02.017
Zulfiqar M, Koen J, Nougaret S, Bolan C, VanBuren W, McGettigan M, Menias C Krukenberg Tumors: Update on Imaging and Clinical Features. AJR Am J Roentgenol. Jul 13, 2020. doi:10.2214/AJR.19.22184
Beer L, Sahin H, Bateman N, Blazic I, Vargas H, Veeraraghavan H, Kirby J, Fevrier-Sullivan B, Freymann J, Jaffe C, Brenton J, Nougaret S, Darcy K, Maxwell G, Conrads T, Huang E, Sala E Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis. Eur Radiol. 2020-4-6. doi:10.1007/s00330-020-06755-3
Abraham J-D, Al Amir Dache Z, Khalyfa A, Jariel-Encontre I, Forné T, Prévostel C, Chouaib S, Gozal D, Thierry A Hypoxia differently modulates the release of mitochondrial and nuclear DNA. Br. J. Cancer. Jan 13, 2020. doi:10.1038/s41416-019-0716-y
Cuer B, Mollevi C, Anota A, Charton E, Juzyna B, Conroy T, Touraine C Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17. BMC Med Res Methodol. 2020;20(1):223. doi:10.1186/s12874-020-01104-w
Dinart D, Fraisse J, Tosi D, Mauguen A, Touraine C, Gourgou S, Le Deley M, Bellera C, Mollevi C GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials. BMC Med Inform Decis Mak. 2020;20(1):134. doi:10.1186/s12911-020-01149-3
Cohen R, Vernerey D, Bellera C, Meurisse A, Henriques J, Paoletti X, Alberts S, Aparicio T, Boukovinas I, Gill S, Goldberg R, Grothey A, Hamaguchi T, Iveson T, Kerr R, Labianca R, Lonardi S, Meyerhardt J, Paul J, Punt C, Saltz L, Saunders M, Schmoll H-J, Shah M, Sobrero A, Souglakos I, Taieb J, Takashima A, Wagner A, Ychou M, Bonnetain F, Gourgou S, Yoshino T, Yothers G, de Gramont A, Shi Q, André T Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative. European Journal of Cancer. 2020;130. doi:10.1016/j.ejca.2020.02.009
Thierry A Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19?. Pediatr. Res.. Jun 03, 2020. doi:10.1038/s41390-020-0996-1
Chabab G, Boissière-Michot F, Mollevi C, Ramos J, Lopez-Crapez E, Colombo P-E, Jacot W, Bonnefoy N, Lafont V Diversity of Tumor-Infiltrating, ?? T-Cell Abundance in Solid Cancers. Cells. 2020;9(6). doi:10.3390/cells9061537
Fabbro M, Colombo P-E, Leaha C, Rouanet P, Carrère S, Gutowski M, Mourregot A, D'Hondt V, Coupier I, Vendrell J, Vilquin P, Pujol P, Solassol J, Mollevi C Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer. Cancers (Basel). 2020;12(8). doi:10.3390/cancers12082184
Sgarbura O, Al Hosni M, Petruzziello A, Figueroa R, Khellaf L, Pissas M-H, Carrère S, Nougaret S, Bibeau F, Quénet F Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept. Int J Hyperthermia. 2020;37(1):585-591. doi:10.1080/02656736.2020.1772511
Mansouri H, Alcaraz L, Mollevi C, Mallavialle A, Jacot W, Boissière-Michot F, Simony-Lafontaine J, Laurent-Matha V, Roger P, Liaudet-Coopman E, Guiu S Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival. Cancers (Basel). 2020;12(5). doi:10.3390/cancers12051244
Jacot W, Mazel M, Mollevi C, D'Hondt V, Cayrefourcq L, Bourgier C, Berrabah F, Lopez-Crapez E, Bidard F-C, Viala M, Maudelonde T, Guiu S, Alix-Panabières C Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer. Clin. Chem.. 2020;66(8):1093-1101. doi:10.1093/clinchem/hvaa121
Institut de Recherche en Cancérologie de
